DR. DOPING

Instructions

Logo DR. DOPING

Instructions / Instruction for use: Veral

I want this, give me price

Active substance Diclofenac

ATX Code M02AB05 Diclofenac

Pharmacological group

NSAIDs - Acetic acid derivatives and related compounds in combinations

Nosological classification (ICD-10)

M06.9 Other specified rheumatoid arthritis

Rheumatoid arthritis,Pain syndrome in rheumatic diseases, Pain in rheumatoid arthritis, Inflammation in rheumatoid arthritis, Degenerative forms of rheumatoid arthritis, Children's rheumatoid arthritis, Exacerbation of rheumatoid arthritis, Acute articular rheumatism, Rheumatic arthritis, Rheumatic polyarthritis, Rheumatoid arthritis, Rheumatic polyarthritis, Rheumatoid arthritis, Rheumatoid arthritis of active course, Rheumatoid arthritis, Rheumatoid polyarthritis, Acute rheumatoid arthritis, Acute rheumatism

M10 Gout

Exacerbation of gout, Acute articular attack with gout, Acute gouty attack, Gouty attack, Recurrent gout attacks, Chronic gout

M15-M19 Osteoarthritis

M25.5 Pain in the joint

Arthralgia, Pain syndrome in musculo-articular diseases, Pain syndrome in osteoarthritis, Pain syndrome in osteoarthritis, Pain syndrome in acute inflammatory diseases of the musculoskeletal system, Pain syndrome in chronic inflammatory diseases of the musculoskeletal system, Pain in the joints, Soreness of the joints, Soreness of joints in severe physical exertion, Painful inflammatory joint damage, Painful conditions of the musculoskeletal system, Painful joint conditions, Painful traumatic affection of joints, Pain in the musculoskeletal system, Pain in Shoulder Joints, Pain in the joints, Joint pain, Joint pain with injuries, Musculoskeletal pain, Pain with osteoarthritis, Pain in the pathology of the joints, Pain in rheumatoid arthritis, Pain in chronic degenerative bone diseases, Pain in chronic degenerative joint diseases, Bone-joint pain, Joint pain, Arthritic pain of rheumatic origin, Articular pain syndrome, Joint pain, Rheumatic pain, Rheumatic pains

M35.3 Rheumatic polymyalgia

Pseudoarthritis rhizomelic, Rheumatic polymyalgia, Pain syndrome in rheumatic diseases, Muscle pain with rheumatism, Extra-articular rheumatism, Extra-articular rheumatic syndrome, Extra-articular rheumatic diseases, Extra-articular rheumatic soft tissue injury, Extra-articular forms of rheumatism, Rheumatic soft tissue damage, Rheumatism of soft tissues, Rheumatic diseases of soft tissues, Rheumatic diseases of the periarticular soft tissues, Rheumatic affections of soft tissues, Rheumatic collagen diseases

M45 Ankylosing spondylitis

Ankylosing spondylarthrosis, Marie-Strumpel disease, Ankylosing spondylitis, Pain syndrome in acute inflammatory diseases of the musculoskeletal system, Pain syndrome in chronic inflammatory diseases of the musculoskeletal system, Bechterew's disease, Ankylosing spondylitis, Diseases of the spinal column, Rheumatic spondylitis, Bechterew-Marie-Strumpel disease

M47 Spondylosis

Spondyloarthrosis, spondylarthrosis, Diseases of the spinal column, spondylosis

M77.9 Other unspecified

Capsule, Periarthritis, Tendonitis, Tendopathy, Periarthropathy

M79.0 Other unspecified rheumatism

Degenerative rheumatic disease, Degenerative and rheumatic diseases of the tendons, Degenerative rheumatic diseases, Localized forms of rheumatism of soft tissues, Rheumatism, Rheumatism with a pronounced allergic component, Rheumatism of the articular and extraarticular, Rheumatic attack, Rheumatic complaints, Rheumatic diseases, Rheumatic disease of the spine, Relapses of rheumatism, Articular and extra-articular rheumatism, Articular and muscular rheumatism, Articular rheumatism, Articular syndrome with rheumatism, Chronic rheumatic pain, Chronic articular rheumatism, Rheumatoid diseases, Rheumatic diseases of the intervertebral disc

R52.2 Other constant pain

Pain syndrome, rheumatic origin, Pain at vertebral lesions, Pain in the chamber, Pain for burns, Pain syndrome weak or moderate, Perioperative pain,Moderate to severe pain, Moderately or weakly expressed pain syndrome, Moderate to severe pain, Ear pain of otitis, Neuropathic pain, neuropathic pain

R60.0 Localized swelling

Allergic laryngeal edema, Local swelling, local edema, localized swelling, Swelling of the lower extremities, Swelling caused by inflammation of the tendon sheath, The swelling after dental surgery, Swelling of the mucosa of the nasopharynx, Swelling of traumatic origin, Traumatic edema, Swelling with injuries, Post-traumatic swelling, Post-traumatic edema, Post-traumatic soft tissue edema, Traumatic edema, Edema oral

T14 Injury of unspecified site

Pain syndrome with injuries and after surgical interventions, Injuries, Extensive trauma to the skin and soft tissues, Muscle and ligament injuries, Injuries, Fibroma traumatic, Acute sport injuries

Composition and form of release

1 tablet, coated with enteric coating, contains diclofenac sodium 25 or 50 mg; in glass bottles of 30 pcs. or in a blister 10 pcs., in a box 1 bottle or 2 and 5 blisters respectively.

100 g of gel - 1 g; in aluminum tubes of 55 grams, in a box of 1 tube.

pharmachologic effect

Pharmacological action - anti-inflammatory, antipyretic, analgesic.

Inhibits cyclooxygenase and inhibits the biosynthesis of PG (prostaglandins).

Indications

Inflammatory, degenerative and rheumatic diseases of the joints and spine: progressive polyarthritis, spondyloarthritis, osteoarthrosis, spondylarthrosis, deforming spondylitis; vertebrogenic syndromes, periarthritis in the humeroscapular region; arthralgia, extraarticular rheumatism, gout, pain and inflammatory syndrome of non-rheumatic origin (table). Local manifestations of inflammatory, degenerative and rheumatic diseases of tendons, articular bags, muscles and other soft tissues; post-traumatic and postoperative inflammation, including edema (gel).

Contraindications

Absolute: hypersensitivity; for tablets - peptic ulcer of the stomach and duodenum, ulcerative colitis, children's age (up to 12 years).

Relative: peptic ulcer in the anamnesis; disorders of kidney and liver function, hematopoiesis; bronchial asthma.

pregnancy and lactation

Contraindicated.

Side effects

Ingestion - headache, dizziness, short temper, irritability, insomnia, fatigue, weakness, sensory and visual impairment, tinnitus, convulsions, epigastric pains, nausea, flatulence, diarrhea, ulceration and bleeding in the digestive tract, renal failure, etc. renal impairment, liver function disorders, anemia, leukopenia, agranulocytosis, thrombocytopenia, rash, itching, urticaria and other allergic and anaphylactoid reactions (including edema of the face, tongue, throat, peripheral edema, especially against hypertension sion), bronchospasm until asthmatic attack, tachycardia, decrease blood pressure, anaphylactic shock. Locally - itching, burning, redness of the skin, rash.

Dosing and Administration

Inside. Tablets - during or after meals, washed down with milk, - at 100-150 mg / day (divided into 2-3 doses).

Outwardly. The gel is applied to the affected area 2-4 g 3-4 times a day and lightly rubbed; treatment can be supplemented with diclofenac ingestion.

Precautionary measures

It should be borne in mind that during the reception of tablets, it is difficult to manage vehicles, mechanisms (due to a decrease in the speed of mental and physical reactions, especially against the background of alcohol consumption). With prolonged therapy it is necessary to regularly monitor the blood picture, stool for concealed blood, indicators of kidney and liver function. It is not recommended to apply the gel under the occlusive dressing. Avoid contact with damaged skin, mucous membranes, eyes.

storage Conditions

In a dry, dark place at a temperature of 10-25 ° C.

Keep out of the reach of children.

Shelf life

tablets, coated with enteric coating 25 mg - 2 years.

tablets, coated with enteric coating 50 mg - 2 years.

gel for external use 1% - 3 years.

Do not use after the expiry date printed on the package.

Someone from the Singapore - just purchased the goods:
Betoptic eye drops 0.5% 5ml